Janus Living, Inc.

Janus Living reported second-quarter revenue rose 45% year over year, adjusted EBITDA increased 34%, and adjusted FFO per share grew 40%, driven by organic growth and approximately $800 million of first-half acquisitions. The company raised its 2026 adjusted FFO guidance to $0.95–$0.98 per share and same-store adjusted NOI growth guidance to 13%–17%. Same-store NOI climbed 19.2%, with occupancy and margins improving, while Janus completed $1.8 billion of year-to-date acquisitions and expanded its operating-partner network from two to 10. As of Aug. 3, the company had $558 million in cash, no debt, and $1.2 billion of available liquidity.

Healthpeak Properties shares have risen 28% over the past three months, outpacing the industry's 12.4% gain. The healthcare real estate company is shifting its portfolio toward lab, outpatient medical, and life plan assets in high-barrier markets, supported by strong leasing momentum and rising occupancy. In the first quarter of 2026, lab occupancy reached 77.7%, up from 77% at year-end 2025, while outpatient medical occupancy held at 91% with 5.4% cash re-leasing spreads on renewals. Senior housing same-store cash net operating income grew 13.8% year over year, and the Janus Living platform posted 35% revenue growth and 42% adjusted EBITDA expansion. Healthpeak generated $267 million from recapitalizations, dispositions, and loan repayments in the quarter, and cash and equivalents rose to $1.17 billion, partly from the Janus Living IPO, while the company also secured a new $400 million delayed-draw term loan.